Comparison of SGLT2 inhibitors with DPP-4 inhibitors combined with metformin in patients with acute myocardial infarction and diabetes mellitus

BACKGROUND: Although sodium-glucose cotransporter 2 inhibitors (SGLT2i) have demonstrated cardiovascular benefits in patients with type 2 diabetes mellitus, real-world evidence regarding their benefits to diabetic patients with acute myocardial infarction (AMI) is insufficient. This study evaluated...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Young Sang, Oh, Seok, Kim, Jin Hwa, Kim, Sang Yong, Jeong, Myung Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362625/
https://www.ncbi.nlm.nih.gov/pubmed/37481509
http://dx.doi.org/10.1186/s12933-023-01914-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362625/
https://www.ncbi.nlm.nih.gov/pubmed/37481509
http://dx.doi.org/10.1186/s12933-023-01914-4

Ejemplares similares